ISRG Share Price Performance
US$0
-541.82 (-100.00%)
Price US$0
Fair ValueUS$592.96
Share Pricen/a
Intuitive Surgical, Inc. Stock Price
- 5 Narratives written by author
- 20 Comments on narratives written by author
- 402 Fair Values set on narratives written by author
ISRG Community Narratives
AN
Fair Value US$592.96 4.8% undervalued intrinsic discount
Rising Demand And Cost Pressures Will Shape Robotic Surgery Outlook
0users have liked this narrative
5users have commented on this narrative
172users have followed this narrative
AN
Fair Value US$447.47 26.2% overvalued intrinsic discount
Global Healthcare Cost Pressures And Tariffs Will Depress Margins
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
Fair Value US$675 16.3% undervalued intrinsic discount
Da Vinci 5 Rollout Will Leverage Aging And Digital Trends
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
From Battle Field to Robotic Surgery
Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making minimally invasive surgery more precise and efficient.Read more
9users have liked this narrative
13users have commented on this narrative
45users have followed this narrative
TO
US$400.91
40.8% overvalued intrinsic discount
Tokyo Fair Value
Revenue growth
12.02% p.a.
Profit Margin
27.81%
Future PE
50x
Share price in 2029
US$540.37
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Catalysts Most Immediate Catalysts (1–2 Years) Increased Adoption of Robotic Surgery: Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times. Expansion into more surgical specialties (e.g., gynecology, urology, general surgery) drives near-term revenue growth.Read more
5users have liked this narrative
2users have commented on this narrative
19users have followed this narrative
UN
US$325.55
73.4% overvalued intrinsic discount
Unike Fair Value
Revenue growth
12% p.a.
Profit Margin
25%
Future PE
45x
Share price in 2030
US$451.73
Rising Demand And Cost Pressures Will Shape Robotic Surgery Outlook
Key Takeaways Expanding global adoption and procedure diversity, coupled with innovative products and digital tools, are fueling recurring revenues, margin stability, and long-term competitive advantage. Increasing regulatory and payer support, driven by strong clinical outcomes, is reducing adoption barriers and supporting durable growth across multiple healthcare markets.Read more
0users have liked this narrative
5users have commented on this narrative
172users have followed this narrative
AN
US$592.96
4.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
13.48% p.a.
Profit Margin
30.33%
Future PE
60.69x
Share price in 2028
US$739.77
Global Healthcare Cost Pressures And Tariffs Will Depress Margins
Key Takeaways Heightened pricing pressures, regulatory scrutiny, and strengthening competition threaten to erode margins and limit long-term revenue and earnings growth. Shifting demographics, industry consolidation, and preference for alternative surgical options will likely reduce demand for robotic systems and challenge market expansion.Read more
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
US$447.47
26.2% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
12.64% p.a.
Profit Margin
25.5%
Future PE
63.43x
Share price in 2028
US$547.67
Da Vinci 5 Rollout Will Leverage Aging And Digital Trends
Key Takeaways Accelerated adoption of da Vinci 5 and digital ecosystem could drive earlier-than-expected system upgrades, higher margins, and strong recurring revenue streams. Expansion into new markets and specialties, supported by manufacturing scale-up, positions the company for outsized, sustainable long-term growth.Read more
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$675
16.3% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
18.63% p.a.
Profit Margin
27.98%
Future PE
74.63x
Share price in 2028
US$826.2
Recently Updated Narratives
TO
From Battle Field to Robotic Surgery
Fair Value: US$400.91 40.8% overvalued intrinsic discount
45 followersusers have followed this narrative
13 commentsusers have commented on this narrative
0 likesusers have liked this narrative
UN
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Fair Value: US$325.55 73.4% overvalued intrinsic discount
19 followersusers have followed this narrative
2 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Demand And Cost Pressures Will Shape Robotic Surgery Outlook
Fair Value: US$592.96 4.8% undervalued intrinsic discount
172 followersusers have followed this narrative
5 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Intuitive Surgical, Inc. Key Details
About ISRG
- Founded
- 1995
- Employees
- 15638
- CEO
- WebsiteView website
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
